MTOR and Alzheimer disease: Chronic unrestrained mTOR activation may be behind AD lysosomal, mitochondrial and metabolic alteration, causing the failure of the blood-brain barrier (BBB) through endothelial cell dysfunction; as well as leading to tau hyperphosphorylation, amyloid plaques formation and aggregation in the brain [38,46].